Gates Foundation Strategic Investment Fund Logo
Share this page:

FierceBiotech: Evotec to acquire Gates Foundation-backed Just Biotherapeutics

By Ben Adams

May 21, 2019

Biotech-CRO hybrid Evotec is continuing its deals, buys and collaborations strategy with its acquisition of U.S. biologics company Just Biotherapeutics.

The German company is spending a small sum, just $90 million, on its latest purchase, but boosts its offering in biologics oncology, central nervous system disorders, pain, inflammation, metabolics and infectious diseases.

Read full text here.